Baird Financial Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,688
Closed -$2.89M 1951
2026
Q1
$2.89M Sell
17,688
-1,996
-10% -$307K ﹤0.01% 919
2025
Q4
$3.43M Sell
19,684
-2,702
-12% -$493K 0.01% 863
2025
Q3
$3.22M Sell
22,386
-3,335
-13% -$409K 0.01% 883
2025
Q2
$2.59M Buy
+25,721
New +$1.97M ﹤0.01% 928
2025
Q1
Sell
-22,289
Closed -$1.54M 1799
2024
Q4
$1.54M Buy
+22,289
New +$1.61M ﹤0.01% 1046
2022
Q1
Sell
-7,651
Closed -$208K 1872
2021
Q4
$208K Hold
7,651
﹤0.01% 1810
2021
Q3
$211K Buy
+7,651
New +$201K ﹤0.01% 1789

Other funds holding INSM

Baird Financial Group's INSM Position: Q2 2026 in Review

Baird Financial Group sold out of Insmed (INSM) in Q2 2026, closing a stake of 17,688 shares — an estimated $2.89M sold.

Baird Financial Group first reported a position in INSM in Q3 2021 and held it in 7 quarters. The position peaked at $3.43M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Baird Financial Group reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Baird Financial Group sold 17,688 Insmed shares in Q2 2026, an estimated $2.89M.
  • Baird Financial Group first reported a position in Insmed in Q3 2021 and held it in 7 quarters.
  • Baird Financial Group's Insmed position peaked at $3.43M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.